Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030028/S013

ARTISAN Myopia Models 204US1W and 206US1W

Ophtec BV · Decision date Apr 24, 2026

FDA DECISIONP030028/S013

What did the FDA decide?

FDA records P030028/S013 as a supplement to PMA P030028, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 24, 2026.

FDA approval order statement

the addition of an alternative third-party testing laboratory for routine bioburden and endotoxin quality control testing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Apr 24, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P030028/S013
Regulatory pathway
PMA supplement
Applicant
Ophtec BV
Product code
MTA
Decision code
OK30
Decision date
Apr 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, intraocular, phakic.

Applicant
Ophtec BV
Product code
MTA
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P030028/S013 received

    Application receipt date recorded by FDA.

  2. P030028/S013 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P030028. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MTA

Product / regulatory recordCompanyPathwayDecision dateSource
STAAR Surgical CompanyPMA supplementMar 4, 2026FDA
STAAR Surgical CompanyPMA supplementNov 14, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ophtec BV

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Schweitzerlaan 15, Groningen, 9728 NR

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records